APA (7th ed.) Citation

Hongell, K., Silva, D. G., Ritter, S., Meier, D. P., & Soilu-Hänninen, M. (2018). Efficacy and safety outcomes in vitamin D supplement users in the fingolimod phase 3 trials. Journal of neurology, 265(2), 348-355. https://doi.org/10.1007/s00415-017-8697-3

Chicago Style (17th ed.) Citation

Hongell, Kira, Diego G. Silva, Shannon Ritter, Daniela Piani Meier, and Merja Soilu-Hänninen. "Efficacy and Safety Outcomes in Vitamin D Supplement Users in the Fingolimod Phase 3 Trials." Journal of Neurology 265, no. 2 (2018): 348-355. https://doi.org/10.1007/s00415-017-8697-3.

MLA (9th ed.) Citation

Hongell, Kira, et al. "Efficacy and Safety Outcomes in Vitamin D Supplement Users in the Fingolimod Phase 3 Trials." Journal of Neurology, vol. 265, no. 2, 2018, pp. 348-355, https://doi.org/10.1007/s00415-017-8697-3.